CD4 and ovarian carcinoma: Similar results were observed in samples isolated from human patients with colorectal, cervical and ovarian carcinoma, including the selective impairment of IFN-γ and IL-2 production in Tim-3+ CD4 T cells isolated from TILs (data not shown).